Company intelligence / Profile preview

Streamline Scientific

Birmingham, Alabama, United Statesstreamlinesci.com ↗

Ownership: Private
Employees: ~61
Development stage: Commercial

Overview

Streamline Scientific operates CLIA-certified reference laboratories providing rapid molecular and toxicology diagnostic results—often within 24 hours. The company was among the first five labs in the U.S. to receive FDA Emergency Use Authorization for COVID testing in March 2020. It has supported over 200 lab setups nationwide and maintains active partnerships with healthcare providers.

Therapeutic areas: Infectious Diseases
Modalities: PCR-based molecular diagnosticsToxicology testing
Industry: Molecular Diagnostics

Partnerships

UroGPO (group purchasing organization supporting urologists with PCR lab implementation)

Beyond the preview

Go deeper on Streamline Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streamline Scientific.

Explore the full profile